Johnson & Johnson I. History A. Founded in 1886 by three brothers: 1. Robert Wood Johnson 2. James Wood Johnson 3. Edward Mead Johnson B. Three main categories: 1. Medical devices (40%) 2. Pharmaceutical (37%) 3. Consumer packaged goods (23%) C. Presented as 250 different operating companies that are spread over 60 countries D. The company has the headquartered in New Jersey E. Listed among the Fortune 500 F. 125 and more years of experience G. Competitive Advantages of the company 1. Work across
Premium Johnson & Johnson Carbon dioxide
The $10‚000 investment made into Johnson and Johnson is a good investment to have in your portfolio. This is because of the stable nature of Johnson and Johnson and the growth trend of the company. Based on the JNJ 10-Ks for the last 5 years ended Jan. 1‚ 2012‚ the revenue trend is growing. Revenues have trended favorably from $61‚095 in the year ended Jan. 2007 to $65‚030 in the year ended Jan. 1‚ 2012. The company is also operating efficiently showing the more stable aspect of this investment
Premium Investment Asset Financial ratios
ESLG 0238 (T&F: 3:25-5:05) SITU SUIYAN (SUSAN) Diversity Plan of Johnson and Johnson I. Overview of company Johnson and Johnson company has a long history‚ which was founded in 1886 by Robert Wood Johnson‚ James Wood Johnson and Edward Mead Johnson in Brunsewick‚ New Jersey. Until now‚ Johnson and Johnson has 250 branches in over 57 countries‚ and it has nearly a hundred consumer brands with thousands of products sold in over 157 countries. The products are including medication‚ first aid
Premium Discrimination Johnson & Johnson
Carolyn Kuzmin Johnson & Johnson Case BUS465 September 21‚ 2014 Primary Issues Johnson and Johnson is facing many quality control problems due to the size and spread of the company The hip recall- and a swarm of other product recalls‚ manufacturing lapses and government inquiries They have struggled with owning up to issues and addressing them quickly enough--- so the brand becomes somewhat tainted The business is still growing with another merger on the horizon so something must be done to address
Premium Medicine Management Strategic business unit
Inequalities of social class‚ race‚ and ethnicity and gender effects the life chances on the macro and micro level. Inequalities that are inherited to the American way of life have caused enormous pain and suffering along with the social class‚ race and gender. People have been abused and held back from living and achieving life potential. It is sadly ironic that a country that was founded on liberty and freedom and would be so mired in the sludge of racism and bigotry. This sad condition
Premium Sociology Equals sign American Civil War
Macro and micro environments both fall into the categories of environmental scanning. The general scope of environmental scanning is that it is a component of global environmental analysis. While analyses are typically carried out on the macro environment‚ the micro environment still has an important role to play. In summary‚ the macro environment is involved with the industries‚ companies‚ markets‚ clients and competitors‚ while the micro environment can be represented by the suppliers‚ competitors
Premium Economics Economy Environment
Paper 1 EXTERAL ANALYSIS Macroenvironmental Analysis: • Economic: Globalization of the pharmaceutical industry is an exciting opportunity to have research and development done at cheaper prices in other countries. However‚ this could be a double edged sword for companies because it is easy for other countries‚ such as India‚ to produce generic versions of the drug in bulk. • Technological: Profitability is determined mainly by the ability to discover new drugs. Technology is at the forefront
Premium Johnson & Johnson
The decision of Johnson & Johnson Acquires Dabao. Di Wang MGT 540 MI004 Professor: Arthur Annechino 20th February 2013 Table of Contents Executive Summary 3 Introduction 4 The reasons of decision 6 Decision making style 7 The problem in decision making process 8 Recommendations 9 Conclusion 11 Reference 12 Executive Summary This paper is talking about the Johnson & Johnson Acquires Dabao. It starts with review the two companies’ history‚ and then shows the
Premium Cosmetics Decision making
The Johnson & Johnson Tylenol Incident In 1982 Johnson and Johnson‚ the pharmaceutical company that makes Tylenol announced a nationwide recall of Tylenol; 31 million bottles and a loss of 100 million dollars. This recall was secondary to the death of seven people in the Chicago area after using Tylenol. An investigation reveled the poisoning were found to be that of an outside source. The Tylenol was contaminated with cyanide from an outside source. Johnson and Johnson ’s response to the poisonings
Premium Tylenol Johnson & Johnson Pharmacology
Technique analysis Firstly‚ Johnson & Johnson Pharmaceutical uses focused differentiation technique in marketing its new proprietary medicines (Saylor 5‚ 2013). In 2013‚ it came up with three major medicines: INVOKANA (canagliflozin)‚ IMBRUVICA (ibrutinib) and OLYSIO (simeprevir) (Johnson & Johnson [J&J]‚ 2013). Each medicine has its own focused market: INVOKANA for Type 2 diabetic patients‚ which affects approximately 26 million people in the United States; IMBRUVICA for people with the rare mantle
Premium Blood sugar Blood sugar Health care